Skip to main content

Find Clinical Trials

Home
Conditions
Neoplasms, Glandular and Epithelial

Clinical trial condition

Neoplasms, Glandular and Epithelial

Explore clinical trials studying Neoplasms, Glandular and Epithelial. Study availability and eligibility vary by location and protocol.

12,876 public trials 2,970 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Glandular and Epithelial trial results

Suspended

AU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver Metastatic Disease

NCT05791448

Conditions: Adenocarcinoma, Advanced Cholangiocarcinoma, Advanced Hepatocellular Carcinoma, +15 more
Locations: Los Angeles County-USC Medical Center Los Angeles, California, United States

USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Suspended

Vudalimab for the Treatment of Locally Advanced or Metastatic Anaplastic Thyroid Cancer or Hurthle Cell Thyroid Cancer

NCT05453799

Conditions: Carcinoma, Locally Advanced Thyroid Gland Anaplastic Carcinoma, Metastatic Thyroid Gland Anaplastic Carcinoma, +5 more
Locations: Northwestern University Chicago, Illinois, United States

M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Suspended

Testing a New Immune Cell Therapy, GD2-Targeted Modified T-cells (GD2CART), in Children, Adolescents, and Young Adults With Relapsed/Refractory Osteosarcoma and Neuroblastoma, GD2-CAR PERSIST Trial

NCT04539366

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, +20 more
Locations: Children's Hospital Los Angeles Los Angeles, California, United States

Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States

Children's Hospital Colorado Aurora, Colorado, United States

National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Withdrawn

Parental Distress and Treatment Adherence in Pediatric Recurrent Medulloblastoma

NCT07660458

Conditions: Glioma, Medulloblastoma, Neoplasms, +8 more
Locations: West China Hospital of Sichuan University Chengdu, Sichuan, China

View Trial Details

Withdrawn

89Zr-Panitumumab for Assessment of Suspected Metastatic Lesions on 18F-FDG-PET/CT in HNSCC

NCT05423197

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations: Stanford Cancer Institute San Francisco, California, United States

View Trial Details

Withdrawn

PDT Plus Vitamin D3 for Anal Dysplasia

NCT02698293

Conditions: Anal Dysplasia, Carcinoma, Carcinoma in Situ, +3 more
Locations: Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details